NMPA Approval

Omeprazole and Sodium Bicarbonate for Suspension（Ⅰ）

Approval Number

国药准字H20254013

Company杭州沐源生物医药科技有限公司

Registration Date

April 30, 2025

Drug Information

Generic Name

奥美拉唑碳酸氢钠干混悬剂(Ⅰ)

Dosage Form

口服混悬剂

Strength

每袋含奥美拉唑20mg与碳酸氢钠1680mg

Drug Type

化学药品

Registration Date

April 30, 2025

Company Information

Applicant Company

Company Name杭州沐源生物医药科技有限公司

Company Address

浙江省杭州市余杭区五常街道高顺路8-1号C座668室

Manufacturing Company

Company Name四川科伦药业股份有限公司

Company Address

资阳经济技术开发区安岳工业园（安岳县石桥铺镇）

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

奥美拉唑碳酸氢钠干混悬剂(Ⅰ) - NMPA 批准文号 | MedPath